BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value ($000): $478,239 (95.0% shares, 5.0% debt)

Holdings (30)

— ARRAY BIOPHARMA INC 14.5%

Value ($000) $69,321 Shares 9,405,817 Est. Cost $4.56 Unrealized —

— CHEMOCENTRYX INC 13.1%

Value ($000) $62,688 Shares 8,303,084 Est. Cost $10.60 Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 7.3%

Value ($000) $34,738 Shares 2,171,108 Est. Cost $10.93 Unrealized +20.0%

— FORWARD PHARMA A/S 7.0%

Value ($000) $33,346 Shares 1,177,481 Est. Cost $21.63 Unrealized —

— ONCOMED PHARMACEUTICALS INC 6.9%

Value ($000) $33,104 Shares 1,284,115 Est. Cost $22.40 Unrealized —

— EXELIXIS INC 5.0%

Value ($000) $23,937 Shares 31,239,000 Est. Cost $0.79 Unrealized —

— ONCOTHYREON INC 4.9%

Value ($000) $23,332 Shares 14,314,178 Est. Cost $1.78 Unrealized —

LGND LIGAND PHARMACEUTICALS INC 4.3%

Value ($000) $20,595 Shares 267,090 Est. Cost $17.99 Unrealized +113.0%

— CONCERT PHARMACEUTICALS INC 4.2%

Value ($000) $20,304 Shares 1,340,659 Est. Cost $12.86 Unrealized —

— TARGACEPT INC 4.1%

Value ($000) $19,766 Shares 6,655,128 Est. Cost $4.29 Unrealized —

— VITAE PHARMACEUTICALS INC 3.9%

Value ($000) $18,472 Shares 1,577,435 Est. Cost $10.26 Unrealized —

— QLT INC 3.4%

Value ($000) $16,226 Shares 4,149,862 Est. Cost $4.17 Unrealized —

CYTK CYTOKINETICS INC 3.0%

Value ($000) $14,285 Shares 2,106,989 Est. Cost $5.41 Unrealized +38.0%

— LOXO ONCOLOGY INC 2.9%

Value ($000) $14,015 Shares 1,125,665 Est. Cost $13.13 Unrealized —

— ARQULE INC 2.9%

Value ($000) $13,831 Shares 6,174,561 Est. Cost $1.91 Unrealized —

EXEL EXELIXIS INC 2.7%

Value ($000) $12,820 Shares 4,988,357 Est. Cost $1.68 Unrealized +38.2%

— FIVE PRIME THERAPEUTICS INC 2.4%

Value ($000) $11,490 Shares 502,832 Est. Cost $17.29 Unrealized —

— GTX INC DEL 1.6%

Value ($000) $7,508 Shares 11,111,111 Est. Cost $0.73 Unrealized —

XENE XENON PHARMACEUTICALS INC 1.4%

Value ($000) $6,601 Shares 391,424 Est. Cost $14.68 Unrealized +25.8%

— SUNESIS PHARMACEUTICALS INC 1.0%

Value ($000) $4,638 Shares 1,893,030 Est. Cost $2.55 Unrealized —

— MAST THERAPEUTICS INC 0.7%

Value ($000) $3,512 Shares 7,241,600 Est. Cost $0.56 Unrealized —

— BIOLINERX LTD 0.7%

Value ($000) $3,167 Shares 1,501,000 Est. Cost $2.16 Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.6%

Value ($000) $2,942 Shares 1,368,500 Est. Cost $2.99 Unrealized —

— REGADO BIOSCIENCES INC 0.5%

Value ($000) $2,297 Shares 1,882,521 Est. Cost $6.73 Unrealized —

— ACHAOGEN INC 0.3%

Value ($000) $1,333 Shares 136,600 Est. Cost $14.91 Unrealized —

— MEI PHARMA INC 0.2%

Value ($000) $1,074 Shares 600,000 Est. Cost $1.79 Unrealized —

— APTOSE BIOSCIENCES INC 0.2%

Value ($000) $907 Shares 166,664 Est. Cost $5.92 Unrealized —

— BIOTA PHARMACEUTIALS INC 0.2%

Value ($000) $807 Shares 350,776 Est. Cost $6.11 Unrealized —

— SOPHIRIS BIO INC 0.1%

Value ($000) $614 Shares 1,060,283 Est. Cost $2.88 Unrealized —

— KALOBIOS PHARMACEUTICALS INC 0.1%

Value ($000) $569 Shares 1,162,000 Est. Cost $2.28 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARRAY BIOPHARMA INC	9,405,817	$69,321	14.5%	$4.56	—	COM	04269X105
—	CHEMOCENTRYX INC	8,303,084	$62,688	13.1%	$10.60	—	COM	16383L106
IRWD	IRONWOOD PHARMACEUTICALS INC	2,171,108	$34,738	7.3%	$10.93	+20.0%	COM CL A	46333X108
—	FORWARD PHARMA A/S	1,177,481	$33,346	7.0%	$21.63	—	SPONSORED ADR	34986J105
—	ONCOMED PHARMACEUTICALS INC	1,284,115	$33,104	6.9%	$22.40	—	COM	68234X102
—	EXELIXIS INC	31,239,000	$23,937	5.0%	$0.79	—	NOTE 4.250% 8/1	30161QAC8
—	ONCOTHYREON INC	14,314,178	$23,332	4.9%	$1.78	—	COM	682324108
LGND	LIGAND PHARMACEUTICALS INC	267,090	$20,595	4.3%	$17.99	+113.0%	COM NEW	53220K504
—	CONCERT PHARMACEUTICALS INC	1,340,659	$20,304	4.2%	$12.86	—	COM	206022105
—	TARGACEPT INC	6,655,128	$19,766	4.1%	$4.29	—	COM	87611R306
—	VITAE PHARMACEUTICALS INC	1,577,435	$18,472	3.9%	$10.26	—	COM	92847N103
—	QLT INC	4,149,862	$16,226	3.4%	$4.17	—	COM	746927102
CYTK	CYTOKINETICS INC	2,106,989	$14,285	3.0%	$5.41	+38.0%	COM NEW	23282W605
—	LOXO ONCOLOGY INC	1,125,665	$14,015	2.9%	$13.13	—	COM	548862101
—	ARQULE INC	6,174,561	$13,831	2.9%	$1.91	—	COM	04269E107
EXEL	EXELIXIS INC	4,988,357	$12,820	2.7%	$1.68	+38.2%	COM	30161Q104
—	FIVE PRIME THERAPEUTICS INC	502,832	$11,490	2.4%	$17.29	—	COM	33830X104
—	GTX INC DEL	11,111,111	$7,508	1.6%	$0.73	—	COM	40052B108
XENE	XENON PHARMACEUTICALS INC	391,424	$6,601	1.4%	$14.68	+25.8%	COM	98420N105
—	SUNESIS PHARMACEUTICALS INC	1,893,030	$4,638	1.0%	$2.55	—	COM NEW	867328601
—	MAST THERAPEUTICS INC	7,241,600	$3,512	0.7%	$0.56	—	COM	576314108
—	BIOLINERX LTD	1,501,000	$3,167	0.7%	$2.16	—	SPONSORED ADR	09071M106
—	ONCOGENEX PHARMACEUTICALS IN	1,368,500	$2,942	0.6%	$2.99	—	COM	68230A106
—	REGADO BIOSCIENCES INC	1,882,521	$2,297	0.5%	$6.73	—	COM	75874Q107
—	ACHAOGEN INC	136,600	$1,333	0.3%	$14.91	—	COM	004449104
—	MEI PHARMA INC	600,000	$1,074	0.2%	$1.79	—	COM NEW	55279B202
—	APTOSE BIOSCIENCES INC	166,664	$907	0.2%	$5.92	—	COM NEW	03835T200
—	BIOTA PHARMACEUTIALS INC	350,776	$807	0.2%	$6.11	—	COM	090694100
—	SOPHIRIS BIO INC	1,060,283	$614	0.1%	$2.88	—	COM NEW	83578Q209
—	KALOBIOS PHARMACEUTICALS INC	1,162,000	$569	0.1%	$2.28	—	COM	48344T100